These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11051772)

  • 1. [Clinical case of the month. Autosomal dominant polycystic kidney: factors in progression of renal insufficiency].
    Xhignesse P; Rorive G
    Rev Med Liege; 2000 Aug; 55(8):767-9. PubMed ID: 11051772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal failure in a patient with autosomal dominant polycystic kidney disease and coexisting dermato-polymyositis: first report in the literature.
    Bahceci F; Sari R; Sarikaya M; Atik E; Karincaoglu Y; Sevinc A
    J Natl Med Assoc; 2004 Jun; 96(6):844-6. PubMed ID: 15233496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rate of progression of renal failure in ADPKD.
    Choukroun G; Itakura Y; Man NK; Christophe JL; Albouze G; Jungers P; Grünfeld JP
    Contrib Nephrol; 1995; 115():28-32. PubMed ID: 8585915
    [No Abstract]   [Full Text] [Related]  

  • 4. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
    Grantham JJ; Chapman AB; Torres VE
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):148-57. PubMed ID: 17699202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does type 2 diabetes mellitus delay renal failure in autosomal dominant polycystic kidney disease?
    Backenroth R; Popovtzer MM
    Ren Fail; 2002 Nov; 24(6):803-13. PubMed ID: 12472202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hypertension according to phenotype and gender in autosomal-dominant polycystic kidney disease.
    Boulahrouz R; Mazeau P; Charasse C; Catroux B; Le Cacheux P; Ang KS; Simon P
    Contrib Nephrol; 1997; 122():17-21. PubMed ID: 9399031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and laboratorial predictors related to progression to chronic kidney disease in patients with autosomal dominant polycystic kidney disease].
    Dehesa-López E; Pérez-Gutiérrez RA; Valdez-Ortiz R; Morales-Buenrostro LE; Correa-Rotter R
    Rev Invest Clin; 2009; 61(5):364-70. PubMed ID: 20184095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
    Ramanathan G; Periyasamy S; Lakkakula BV
    Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal failure and cystic kidney diseases].
    Correas JM; Joly D; Chauveau D; Richard S; Hélénon O
    J Radiol; 2011 Apr; 92(4):308-22. PubMed ID: 21549887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension.
    Geberth S; Stier E; Zeier M; Mayer G; Rambausek M; Ritz E
    J Am Soc Nephrol; 1995 Dec; 6(6):1643-8. PubMed ID: 8749692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureteropelvic junction obstruction in association with autosomal dominant polycystic kidney disease: a case report in a trauma patient.
    Zaslau S; Talug C; Boo S; Roberts L
    W V Med J; 2008; 104(1):15-7. PubMed ID: 18335780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tolvaptan and autosomal dominant polycystic kidney disease in the adult: let's give time to the "TEMPO" trial (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes)].
    Lacquaniti A
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 25083527
    [No Abstract]   [Full Text] [Related]  

  • 15. Least square regression analysis of arterial pressure estimators contributing to early renal failure in ADPKD.
    Gonzalo A; Gallego A; Rivera M; Orte L; Ortuño J
    Contrib Nephrol; 1995; 115():171-6. PubMed ID: 8585910
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystic changes of breast in a family with autosomal dominant polycystic kidney disease.
    Maleki D; Ghafari A
    Iran J Kidney Dis; 2009 Oct; 3(4):246-8. PubMed ID: 19841531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of autosomal dominant polycystic kidney disease: recent developments.
    Grantham JJ
    Contrib Nephrol; 1997; 122():1-9. PubMed ID: 9399029
    [No Abstract]   [Full Text] [Related]  

  • 18. Autosomal dominant polycystic kidney disease.
    Beebe DK
    Am Fam Physician; 1996 Feb; 53(3):925-31. PubMed ID: 8594868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.
    Panizo N; Goicoechea M; García de Vinuesa S; Arroyo D; Yuste C; Rincón A; Verdalles U; Ruiz-Caro C; Quiroga B; Luño J
    Nefrologia; 2012; 32(2):197-205. PubMed ID: 22425799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus.
    Pietrzak-Nowacka M; Rózanski J; Safranow K; Kedzierska K; Dutkiewicz G; Ciechanowski K
    Arch Med Res; 2006 Apr; 37(3):360-4. PubMed ID: 16513485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.